Stock Analysis

Jiangxi Rimag Group And 2 Other Top Insider-Owned Growth Stocks

SHSE:605136
Source: Shutterstock

As global markets continue to experience mixed performances, with major indices like the S&P 500 and Nasdaq Composite hitting record highs while others such as the Russell 2000 decline, growth stocks have emerged as standout performers. In this environment, companies with high insider ownership often attract attention due to their potential for aligned interests between management and shareholders. This article explores Jiangxi Rimag Group and two other notable insider-owned growth stocks that may be of interest in today's market landscape.

Advertisement

Top 10 Growth Companies With High Insider Ownership

NameInsider OwnershipEarnings Growth
SKS Technologies Group (ASX:SKS)27%24.8%
Kirloskar Pneumatic (BSE:505283)30.3%26.3%
Seojin SystemLtd (KOSDAQ:A178320)30.9%39.9%
Archean Chemical Industries (NSEI:ACI)22.9%41.3%
Laopu Gold (SEHK:6181)36.4%34.2%
Medley (TSE:4480)34%31.7%
Fine M-TecLTD (KOSDAQ:A441270)17.2%131.1%
HANA Micron (KOSDAQ:A067310)18.4%110.9%
Brightstar Resources (ASX:BTR)16.2%84.6%
Findi (ASX:FND)34.8%112.9%

Click here to see the full list of 1516 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

Jiangxi Rimag Group (SEHK:2522)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Jiangxi Rimag Group Co., Ltd. operates medical imaging centers in China and has a market cap of HK$20.38 billion.

Operations: The company generates revenue from its Medical Labs & Research segment, amounting to CN¥812.85 million.

Insider Ownership: 24.3%

Jiangxi Rimag Group is poised for significant growth, with earnings forecasted to rise 71.84% annually and revenue expected to grow by 30% per year, outpacing the Hong Kong market. Despite a low return on equity projection of 9.7%, no substantial insider trading activity has been reported recently. Recent board changes include the retirement of several directors and supervisors without any noted disagreements, ensuring stability in governance transitions.

SEHK:2522 Earnings and Revenue Growth as at Dec 2024
SEHK:2522 Earnings and Revenue Growth as at Dec 2024

Chifeng Jilong Gold MiningLtd (SHSE:600988)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Chifeng Jilong Gold Mining Co., Ltd. is a company engaged in the mining of gold and non-ferrous metals, with a market capitalization of CN¥28.49 billion.

Operations: Chifeng Jilong Gold Mining Co., Ltd. generates revenue primarily from its operations in gold and non-ferrous metal mining.

Insider Ownership: 16.1%

Chifeng Jilong Gold Mining Ltd. demonstrates strong growth potential with earnings projected to increase by 21.86% annually, though this is slightly below the broader CN market's growth rate. The company reported robust financial performance for the first nine months of 2024, with revenue reaching CNY 6.22 billion and net income doubling from the previous year to CNY 1.11 billion. Trading at a significant discount to estimated fair value, it offers good relative value compared to peers and industry standards.

SHSE:600988 Ownership Breakdown as at Dec 2024
SHSE:600988 Ownership Breakdown as at Dec 2024

Shanghai Lily&Beauty CosmeticsLtd (SHSE:605136)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shanghai Lily&Beauty Cosmetics Co., Ltd. operates in China, offering online cosmetics marketing and retailing services with a market cap of CN¥3.92 billion.

Operations: Shanghai Lily&Beauty Cosmetics Co., Ltd.'s revenue primarily comes from its online cosmetics marketing and retailing services in China.

Insider Ownership: 32.5%

Shanghai Lily&Beauty Cosmetics Ltd. is expected to experience significant growth, with earnings projected to increase by 56.2% annually, outpacing the broader CN market. Despite reporting a net loss of CNY 27.8 million for the first nine months of 2024, this marks an improvement from the previous year. The stock trades at a substantial discount to its estimated fair value, suggesting potential undervaluation despite recent revenue declines from CNY 1.93 billion to CNY 1.23 billion year-over-year.

SHSE:605136 Earnings and Revenue Growth as at Dec 2024
SHSE:605136 Earnings and Revenue Growth as at Dec 2024

Summing It All Up

Looking For Alternative Opportunities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com